OPKO Health Reports 2016 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St rebounds with broad gains as oil slides sharply
- Brent hits lowest since before start of Iran war as more tankers exit Hormuz, easing supply
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Opko Health (OPK) PT Lowered to $8 at Jefferies Following 4Q Miss
March 2, 2017 7:38 AM ESTJefferies lowered its price target on Opko Health (NASDAQ: OPK) to $8.00 (from $10.00) while maintaining a Hold rating. 4Q revenues of $275M came in well below consensus estimates, mainly on weaker BRLI trends.
Analyst Brandon Couillard commented, "4Q16 revenues came in well below... More
OPKO Health (OPK) Reports In-Line Q4 EPS
March 1, 2017 4:19 PM ESTOPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.04), in-line with the analyst estimate of ($0.04). Revenue for the quarter came in at $275.5 million versus the consensus estimate of $310.82 million.
Consolidated revenues for the three months ended December 31, 2016 of $275.5 million were consistent with the comparable period of 2015 revenue of $276.2 million. The 2016 period benefited from... More